デフォルト表紙
市場調査レポート
商品コード
1705414

サル痘検査の世界市場レポート 2025年

Monkey Pox Testing Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
サル痘検査の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サル痘検査の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.4%で18億1,000万米ドルに成長します。予測期間の成長は、医療費の増加、ポイントオブケア(POC)検査の開発、家庭用検査キットの成長、アクセシビリティと手頃な価格への注目、ヘルスケアインフラの改善などに起因しています。予測期間における主な動向としては、サーベイランスシステムとの統合、デジタルヘルスツールとの統合、技術的進歩、公衆衛生システムへの統合、診断研究の進歩などが挙げられます。

サル痘の罹患率の上昇は、サル痘検査市場の今後の成長を促進すると予想されます。サル痘は、天然痘ウイルスに近縁のオルソポックスウイルス属に属するサル痘ウイルスによって引き起こされるまれなウイルス性疾患です。サル痘患者の増加は、ヒトからヒトへのトランスミッションの増加、世界の旅行、天然痘ワクチン接種プログラムの中止による免疫力の低下に起因しています。サル痘検査は、感染者の早期発見、タイムリーな治療と隔離による感染拡大防止、発生状況の追跡とトランスミッションの理解など、重要な役割を果たしています。例えば、2022年5月、スウェーデンに本拠を置く政府機関である欧州疾病予防管理センター(ECDC)は、14州54保健区域において、2022年1月から4月までに1,152件のサル痘疑い症例が報告され、55人が死亡し、症例致死率は4.8%でした。これは、2021年の同時期と比較して、疑い症例が138件、死亡例が14件増加し、症例致死率が10.1%と高くなったことを示しています。その結果、サル痘の発生率の増加がサル痘検査市場の拡大を牽引しています。

サル痘検査市場の主要企業は、正確性、利便性、アクセシビリティを向上させるため、唾液ベースのサル痘検査などの高度な診断ソリューションの開発に注力しています。唾液ベースのサル痘検査は、唾液サンプルを用いてサル痘ウイルスを検出する方法です。例えば、2022年7月、米国の医療検査機関であるフローヘルス社は、サル痘の唾液ベースのPCR検査を導入しました。この革新的な検査法は、より簡便で非侵襲的なウイルス検出法を提供し、高い感度と特異性、迅速な遺伝物質の増幅、様々な用途への適応性を特徴としています。サンプル採取を簡素化しながら、ウイルス量の定量分析と病原体の直接検出を可能にします。この検査の大きな利点は、目に見える病変が現れる前にウイルスを検出できることであり、これは早期発見とウイルスの蔓延を抑えるために極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界サル痘検査PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のサル痘検査市場:成長率分析
  • 世界のサル痘検査市場の実績:規模と成長, 2019-2024
  • 世界のサル痘検査市場の予測:規模と成長, 2024-2029, 2034F
  • 世界サル痘検査総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のサル痘検査市場:技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ポリメラーゼ連鎖反応(PCR)
  • ラテラルフローアッセイ(LFA)
  • その他のテクノロジー
  • 世界のサル痘検査市場モード別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 臨床検査
  • ポイントオブケア検査
  • 世界のサル痘検査市場:最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院と診療所
  • 診断検査室
  • その他の用途
  • 世界のサル痘検査市場ポリメラーゼ連鎖反応(PCR)の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • リアルタイムPCR(qPCR)
  • 逆転写PCR(RT-PCR)
  • マルチプレックスPCR
  • 世界のサル痘検査市場ラテラルフローアッセイ(LFA)のサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫クロマトグラフィーによるラテラルフローアッセイ
  • 迅速抗原検出キット
  • 世界のサル痘検査市場その他のテクノロジーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ELISA(酵素免疫測定法)
  • CRISPRベースのテスト
  • 血清学的検査(抗体検出)
  • 核酸配列に基づく増幅(NASBA)

第7章 地域別・国別分析

  • 世界のサル痘検査市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のサル痘検査市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • サル痘検査市場:競合情勢
  • サル痘検査市場:企業プロファイル
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • bioMerieux S.A.
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Cepheid Inc.
  • Aegis Sciences Corporation
  • Chembio Diagnostics Inc.
  • Flow Health Inc.
  • SeraCare Life Sciences Inc.
  • BioGX Inc.
  • Applied DNA Sciences Inc.
  • CerTest Biotec S.L.
  • Altona Diagnostics GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • サル痘検査市場2029:新たな機会を提供する国
  • サル痘検査市場2029:新たな機会を提供するセグメント
  • サル痘検査市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30724

Monkeypox testing refers to the diagnostic process used to detect the presence of the monkeypox virus in an individual. This testing is crucial for identifying and confirming cases of monkeypox, a viral zoonotic disease that can be transmitted from animals to humans and between humans.

The main technologies for money pox testing are polymerase chain reaction (PCR), lateral flow assay (LFA), and others. Polymerase Chain Reaction (PCR) is a molecular technique used to amplify and detect the DNA of the monkeypox virus in patient samples, making it a key tool for accurate and early diagnosis of the disease. It enables rapid identification of viral genetic material, crucial for controlling outbreaks. Testing modes include laboratory testing and point-of-care testing, with end users such as hospitals and clinics, diagnostic laboratories, and others.

The money pox testing market research report is one of a series of new reports from The Business Research Company that provides money pox testing market statistics, including the money pox testing industry's global market size, regional shares, competitors with a money pox testing market share, detailed money pox testing market segments, market trends and opportunities, and any further data you may need to thrive in the money pox testing industry. This money pox testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The monkey pox testing market size has grown steadily in recent years. It will grow from $1.46 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing government funding and initiatives, increasing demand to provide rapid tests, increasing testing capacity, increasing research and development, and increasing public awareness campaigns.

The monkey pox testing market size is expected to see steady growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to rising healthcare expenditures, development of point-of-care (POC) tests, growth in at-home testing kits, focus on accessibility and affordability, and healthcare infrastructure improvement. Major trends in the forecast period include integration of testing with surveillance systems, integration with digital health tools, technological advancements, integration into public health systems and advancements in diagnostic research.

The rising incidence of monkeypox is expected to drive growth in the monkeypox testing market moving forward. Monkeypox is a rare viral disease caused by the monkeypox virus, which belongs to the orthopoxvirus genus, closely related to the smallpox virus. The increase in monkeypox cases is attributed to heightened human-to-human transmission, global travel, and decreased immunity due to the cessation of smallpox vaccination programs. Monkeypox testing plays a crucial role by enabling early identification of infected individuals, facilitating timely treatment and isolation to curb further spread, and aiding in tracking outbreaks and understanding transmission patterns. For example, in May 2022, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported 1,152 suspected monkeypox cases from January to April 2022, resulting in 55 deaths and a case-fatality rate of 4.8%, across 54 health zones in 14 provinces. This represents an increase of 138 suspected cases and 14 deaths compared to the same period in 2021, leading to a higher case-fatality rate of 10.1%. Consequently, the growing incidence of monkeypox is driving the expansion of the monkeypox testing market.

Major companies in the monkeypox testing market are focusing on developing advanced diagnostic solutions, such as saliva-based monkeypox tests, to improve accuracy, convenience, and accessibility. Saliva-based monkeypox testing is a method that detects the monkeypox virus using saliva samples. For example, in July 2022, Flow Health, a US-based medical laboratory, introduced a saliva-based PCR test for monkeypox. This innovative test offers a more convenient and non-invasive method for virus detection, featuring high sensitivity and specificity, rapid genetic material amplification, and adaptability for various uses. It enables quantitative analysis of viral loads and direct pathogen detection while simplifying sample collection. A significant advantage of this test is its ability to detect the virus before visible lesions appear, which is crucial for early detection and reducing the spread of the virus.

In September 2023, BioNTech, a UK-based biotechnology firm, entered into a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) for an undisclosed amount. This collaboration aims to accelerate the development of effective vaccines for mpox (formerly known as monkeypox), a disease that has gained significant attention due to recent outbreaks. The Coalition for Epidemic Preparedness Innovations (CEPI) is a UK-based public-private entity dedicated to advancing vaccine development.

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monkey pox testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monkey pox testing market consist of revenues earned by entities by providing services such as laboratory testing, diagnostic consultation, sample collection, result reporting, contact tracing, and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The monkey pox testing market also includes of sales of serological testing equipment, centrifuges, refrigeration units, biosafety cabinets, automated nucleic acid extractors, and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monkey Pox Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monkey pox testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monkey pox testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The monkey pox testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Polymerase Chain Reaction (PCR); Lateral Flow Assay (LFA); Other Technologies
  • 2) By Mode: Laboratory Testing; Point Of Care Testing
  • 3) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Other End-Uses
  • Subsegments:
  • 1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Multiplex PCR
  • 2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays; Rapid Antigen Detection Kits
  • 3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay); CRISPR-based Testing; Serological Tests (Antibody Detection); Nucleic Acid Sequence-Based Amplification (NASBA)
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Mayo Clinic Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Monkey Pox Testing Market Characteristics

3. Monkey Pox Testing Market Trends And Strategies

4. Monkey Pox Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Monkey Pox Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Monkey Pox Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Monkey Pox Testing Market Growth Rate Analysis
  • 5.4. Global Monkey Pox Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Monkey Pox Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Monkey Pox Testing Total Addressable Market (TAM)

6. Monkey Pox Testing Market Segmentation

  • 6.1. Global Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Lateral Flow Assay (LFA)
  • Other Technologies
  • 6.2. Global Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing
  • Point Of Care Testing
  • 6.3. Global Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Other End-Uses
  • 6.4. Global Monkey Pox Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time PCR (qPCR)
  • Reverse Transcription PCR (RT-PCR)
  • Multiplex PCR
  • 6.5. Global Monkey Pox Testing Market, Sub-Segmentation Of Lateral Flow Assay (LFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunochromatographic Lateral Flow Assays
  • Rapid Antigen Detection Kits
  • 6.6. Global Monkey Pox Testing Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • CRISPR-based Testing
  • Serological Tests (Antibody Detection)
  • Nucleic Acid Sequence-Based Amplification (NASBA)

7. Monkey Pox Testing Market Regional And Country Analysis

  • 7.1. Global Monkey Pox Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Monkey Pox Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monkey Pox Testing Market

  • 8.1. Asia-Pacific Monkey Pox Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monkey Pox Testing Market

  • 9.1. China Monkey Pox Testing Market Overview
  • 9.2. China Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monkey Pox Testing Market

  • 10.1. India Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monkey Pox Testing Market

  • 11.1. Japan Monkey Pox Testing Market Overview
  • 11.2. Japan Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monkey Pox Testing Market

  • 12.1. Australia Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monkey Pox Testing Market

  • 13.1. Indonesia Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monkey Pox Testing Market

  • 14.1. South Korea Monkey Pox Testing Market Overview
  • 14.2. South Korea Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monkey Pox Testing Market

  • 15.1. Western Europe Monkey Pox Testing Market Overview
  • 15.2. Western Europe Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monkey Pox Testing Market

  • 16.1. UK Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monkey Pox Testing Market

  • 17.1. Germany Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monkey Pox Testing Market

  • 18.1. France Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monkey Pox Testing Market

  • 19.1. Italy Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monkey Pox Testing Market

  • 20.1. Spain Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monkey Pox Testing Market

  • 21.1. Eastern Europe Monkey Pox Testing Market Overview
  • 21.2. Eastern Europe Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monkey Pox Testing Market

  • 22.1. Russia Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monkey Pox Testing Market

  • 23.1. North America Monkey Pox Testing Market Overview
  • 23.2. North America Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monkey Pox Testing Market

  • 24.1. USA Monkey Pox Testing Market Overview
  • 24.2. USA Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monkey Pox Testing Market

  • 25.1. Canada Monkey Pox Testing Market Overview
  • 25.2. Canada Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monkey Pox Testing Market

  • 26.1. South America Monkey Pox Testing Market Overview
  • 26.2. South America Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monkey Pox Testing Market

  • 27.1. Brazil Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monkey Pox Testing Market

  • 28.1. Middle East Monkey Pox Testing Market Overview
  • 28.2. Middle East Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monkey Pox Testing Market

  • 29.1. Africa Monkey Pox Testing Market Overview
  • 29.2. Africa Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monkey Pox Testing Market Competitive Landscape And Company Profiles

  • 30.1. Monkey Pox Testing Market Competitive Landscape
  • 30.2. Monkey Pox Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Monkey Pox Testing Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Sonic Healthcare Limited
  • 31.4. bioMerieux S.A.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Cepheid Inc.
  • 31.8. Aegis Sciences Corporation
  • 31.9. Chembio Diagnostics Inc.
  • 31.10. Flow Health Inc.
  • 31.11. SeraCare Life Sciences Inc.
  • 31.12. BioGX Inc.
  • 31.13. Applied DNA Sciences Inc.
  • 31.14. CerTest Biotec S.L.
  • 31.15. Altona Diagnostics GmbH

32. Global Monkey Pox Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monkey Pox Testing Market

34. Recent Developments In The Monkey Pox Testing Market

35. Monkey Pox Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Monkey Pox Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Monkey Pox Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Monkey Pox Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer